Details

DSEN Abstract: Safety, effectiveness, and cost-effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: a systematic review and network meta-analysis - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Mar 11, 2026 · edition #8
Timestamp
2026-03-11T14:05:22.807Z
Language
en
Original URL
https://cihr-irsc.gc.ca/e/51394.html?wbdisable=true
Replay URL
https://replay.healtharchive.ca/job-8/20260311140522/https://cihr-irsc.gc.ca/e/51394.html?wbdisable=true#ha_snapshot=1047970
ID
1047970
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

ViewView diffRaw HTML ↗Metadata JSON ↗CiteReport issueAll snapshots

Other snapshots

Archived page preview